Matthew L. Wein - 05 Mar 2026 Form 4 Insider Report for Metagenomi Therapeutics, Inc. (MGX)

Role
Title: General Counsel, Compliance Officer and Corporate Secretary
Signature
/s/ Matthew L. Wein
Issuer symbol
MGX
Transactions as of
05 Mar 2026
Net transactions value
-$771
Form type
4
Filing time
09 Mar 2026, 17:16:17 UTC
Previous filing
08 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wein Matthew Title: General Counsel, Compliance Officer and Corporate Secretary C/O METAGENOMI THERAPEUTICS, INC., 5959 HORTON STREET, 7TH FLOOR, EMERYVILLE /s/ Matthew L. Wein 09 Mar 2026 0002009713

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGX Common Stock Sale $771 -482 -0.42% $1.60 114,549 05 Mar 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on each of April 1, 2024 and April 1, 2025, and does not represent a volitional trade by the Reporting Person.

Remarks:

Title: General Counsel, Compliance Officer and Corporate Secretary